Protein succinylation associated with the progress of hepatocellular carcinoma. Issue 22 (29th October 2022)

• Record Type: Journal Article
• Authors: Bai, Wenhui; Cheng, Li; Xiong, Liangkun; Wang, Maoming; Liu, Hao; Yu, Kaihuan; Wang, Weixing
• Is Part Of: Journal of cellular and molecular medicine. Volume 26:Issue 22(2022)
• Page Start: 5702
• Page End: 5712
• Publication Date: 2022-10-29
• Subjects: hepatocellular carcinoma -- model -- prognosis -- succinylation; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.17507
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Although post‐translational modification is critical to tumorigenesis, how succinylation modification of lysine sites influences hepatocellular carcinoma (HCC) remains obscure. 90 tumours and paired adjacent normal tissue of liver cancer were enrolled for succinylation staining. 423 HCC samples with 20 genes related to succinylation modification from TCGA were downloaded for model construction. Statistical methods were employed to analyse the data, including the Non‐Negative Matrix Factorization (NMF) algorithm, t‐Distributed Stochastic Neighbour Embedding (t‐SNE) algorithm, and Cox regression analysis. The staining pan‐succinyllysine antibody staining indicated that tumour tissues had a higher succinyllysine level than adjacent tissues ( p < 0.001), which could be associated with a worse prognosis ( p = 0.02). The survival was associated with pathological stage, tumour recurrence status and succinyllysine intensity in the univariate or multivariable cox survival analysis model. The risk model from 20 succinyllysine‐related genes had the best prognosis prediction. The high expression of succinylation modification in HCC contributed to the worse patient survival prognosis. Model construction of 20 genes related to succinylation modification (MEAF6, OXCT1, SIRT2, CREBBP, KAT5, SIRT4, SIRT6, SIRT7, CPT1A, GLYATL1, SDHA, SDHB, SDHC, SDHD, SIRT1, SIRT3, SIRT5, SUCLA2, SUCLG1 and SUCLG2) could be reliable in predicting prognosis in HCC.